NCT01203774View on ClinicalTrials.gov

Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the Hospital

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Diabetes
Interventions
DRUG

Glargine insulin

20-180 units per day

Trial Locations (1)

80045

University of Colorado Denver, Aurora

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of Colorado, Denver

OTHER